trial

Recovery Therapy Trial

NCTId NCT00239122
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 94
Sponsored by Melbourne Health
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
94
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
None
Start
2000-06
Primary completion
—
Eligibility
ALL · 16 Years · 65 Years

Interventions & indications

Drugs
Recovery Therapy (Cognitive Behaviour Therapy for psychosis)

Sponsors

Melbourne HealthLead Sponsor
William Buckland FoundationCollaborator

Investigators

1
John Farhall, BA(Hons), MAPrincipal Investigator

Sites

2 total
Epping, AustraliaPreston, Australia

Facts & assertions

3 sourced
Enrollment
94
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
Recovery Therapy (Cognitive Behaviour Therapy for psychosis)
drug
lead_sponsor
Melbourne Health
company
collaborator
William Buckland Foundation
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
Schizophrenia
indication
investigator
John Farhall, BA(Hons), MA
person